中/EN Contact/Message
Innovate
Vivjoa
Vivjoa
departments:妇产科
drug:胶囊
Active:oteseconazole
indication:降低有RVVC病史且没有生殖潜力的女性复发性外阴阴道念珠菌病(RVVC)的发病率
Licensor:Mycovia Pharms
Approved Country/Region:FDA
Approval time:2022-04-26